Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020

SELL
$54.34 - $94.85 $17.7 Million - $30.8 Million
-325,000 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $9.64 Million - $26 Million
325,000 New
325,000 $20.9 Million
Q1 2020

May 08, 2020

SELL
$17.78 - $31.58 $19.4 Million - $34.5 Million
-1,091,815 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$13.93 - $21.28 $15.2 Million - $23.2 Million
1,091,815 New
1,091,815 $21.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $18.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Segantii Capital Management LTD Portfolio

Follow Segantii Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Segantii Capital Management LTD with notifications on news.